Taiwan’s COVID Vaccine

Published

By Asnaya Chou/Yin Khvat

Taiwan’s only locally produced vaccine, Medigen, faced criticism when it was approved for Emergency Use Authorization, or EUA, ahead of completing Phase III trials. In an exclusive interview with Taiwan+, Medigen’s president Charles Chen tackles the criticism head on and explains how very few COVID cases in Taiwan triggered an entirely new way of approving vaccines.